Cryo-Cell International, Inc.
CCEL
$3.40
$0.041.19%
AMEX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 31.13M | 31.28M | 31.57M | 31.75M | 31.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 31.13M | 31.28M | 31.57M | 31.75M | 31.99M |
| Cost of Revenue | 11.23M | 11.41M | 11.74M | 7.28M | 7.60M |
| Gross Profit | 19.90M | 19.87M | 19.83M | 24.47M | 24.39M |
| SG&A Expenses | 18.95M | 18.59M | 18.22M | 18.78M | 19.07M |
| Depreciation & Amortization | 737.70K | 743.50K | 751.50K | 763.70K | 772.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.23M | 31.09M | 31.08M | 27.42M | 28.17M |
| Operating Income | -103.90K | 191.40K | 482.30K | 4.33M | 3.82M |
| Income Before Tax | -2.55M | -2.80M | -2.34M | 1.45M | 1.65M |
| Income Tax Expenses | -81.50K | -135.40K | 92.30K | 1.93M | 1.82M |
| Earnings from Continuing Operations | -2.47 | -2.67 | -2.43 | -0.47 | -0.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.47M | -2.67M | -2.43M | -473.50K | -171.20K |
| EBIT | -103.90K | 191.40K | 482.30K | 4.33M | 3.82M |
| EBITDA | 871.10K | 1.17M | 1.47M | 5.32M | 4.81M |
| EPS Basic | -0.31 | -0.33 | -0.30 | -0.06 | -0.02 |
| Normalized Basic EPS | -0.15 | -0.14 | -0.12 | 0.16 | 0.12 |
| EPS Diluted | -0.31 | -0.34 | -0.31 | -0.07 | -0.03 |
| Normalized Diluted EPS | -0.15 | -0.14 | -0.12 | 0.16 | 0.12 |
| Average Basic Shares Outstanding | 32.22M | 32.25M | 32.28M | 32.29M | 32.29M |
| Average Diluted Shares Outstanding | 32.24M | 32.31M | 32.45M | 32.47M | 32.57M |
| Dividend Per Share | 0.00 | 0.15 | 0.40 | 0.65 | 0.65 |
| Payout Ratio | 0.00% | -45.43% | -133.01% | -1,109.12% | -3,067.58% |